| Literature DB >> 28719259 |
Ousmane Maiga1, Miriam Andrada Sas2, Kyle Rosenke3, Badian Kamissoko4, Marc Mertens2, Nafomon Sogoba1, Abdallah Traore4, Modibo Sangare5, Mamadou Niang4, Tom G Schwan6, Hamidou Moussa Maiga5, Sekou F Traore1, Heinz Feldmann3,7, David Safronetz7,8, Martin H Groschup2.
Abstract
AbstractCrimean-Congo hemorrhagic fever is a tick-borne disease caused by the arbovirus Crimean-Congo hemorrhagic fever virus (CCHFV, family Bunyaviridae, genus Nairovirus). CCHFV can cause a severe hemorrhagic fever with high-case fatality rates in humans. CCHFV has a wide geographic range and has been described in around 30 countries in the Middle East, Asia, Europe, and Africa including Mali and neighboring countries. To date, little is known about the prevalence rates of CCHFV in Mali. Here, using banked bovine serum samples from across the country, we describe the results of a seroepidemiological study for CCHFV aimed at identifying regions of circulation in Mali. In total, 1,074 serum samples were tested by a modified in-house CCHFV-IgG-enzyme-linked immunosorbent assay (ELISA) with confirmatory testing by commercial ELISA and immunofluorescence assay. Overall, 66% of samples tested were positive for CCHFV-specific IgG antibodies. Regional seroprevalence rates ranged from 15% to 95% and seemed to correlate with cattle density. Our results demonstrate that CCHFV prevalence is high in many regions in Mali and suggest that CCHFV surveillance should be established.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28719259 PMCID: PMC5462568 DOI: 10.4269/ajtmh.16-0818
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345